Search results
Results from the WOW.Com Content Network
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing ...
The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. [26] It owns brands (like Viagra , Xanax , Lipitor ), [ 6 ] [ 27 ] generics , including branded and complex generics, biosimilars , [ 28 ] [ 29 ] and over-the-counter (OTC) drugs and active pharmaceutical ingredients .
Sildenafil's brand name, Viagra, is widely recognized in popular culture, and the drug's association with treating erectile dysfunction has led to its recreational use. [33] The reasons behind such use include the belief that the drug increases libido, improves sexual performance, [ 33 ] or permanently increases penis size. [ 34 ]
You shouldn’t take Viagra for fun. Brand-name ED drugs like Cialis (tadalafil), Levitra(vardenafil), Stendra and others that are FDA-approved to treat ED are also not safe to use without medical ...
Whether you’re one of the 30 million men who have (ED) or not, you’ve almost certainly heard of Viagra. Maybe you even know about other ED medications, like Levitra or Stendra or Cialis, too.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
It looks like Pfizer's (NYS: PFE) Viagra won't have any little blue generic competition for a while. During a court case with Teva Pharmaceutical (NAS: TEVA) , Pfizer successfully defended its ...
In October 2020, Hims closed a deal with Oaktree Capital Management to go public through a blank check company, reaching a valuation of $1.6 billion. [7] As part of the deal, the company was renamed Hims & Hers Health Inc. [11] The transaction was completed in January 2021, and the company started trading publicly on the New York Stock Exchange.